Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) Short Interest Update

Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) saw a significant increase in short interest during the month of August. As of August 15th, there was short interest totalling 1,661,100 shares, an increase of 5.0% from the July 31st total of 1,581,500 shares. Based on an average daily volume of 1,680,700 shares, the days-to-cover ratio is presently 1.0 days.

Elite Pharmaceuticals Trading Down 0.8 %

ELTP opened at $0.28 on Tuesday. The company has a quick ratio of 2.09, a current ratio of 3.08 and a debt-to-equity ratio of 0.08. Elite Pharmaceuticals has a 52 week low of $0.06 and a 52 week high of $0.31. The business’s 50 day moving average is $0.20 and its two-hundred day moving average is $0.17. The firm has a market cap of $295.59 million, a price-to-earnings ratio of 27.70 and a beta of 0.11.

Elite Pharmaceuticals Company Profile

Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.